Recent data from the Centers for Disease Control and Prevention (CDC) reveals a promising trend: rates of sexually transmitted diseases (STDs) among U.S. adults have decreased over the past year. However, the situation is starkly different for newborns, as cases of congenital syphilis continue to climb, raising significant public health concerns.
The CDC's provisional data for 2024 indicates a third consecutive year of declining gonorrhea cases, alongside a second year of reduced adult cases of chlamydia and the more infectious forms of syphilis. In the past year, approximately 1.5 million chlamydia cases, 543,000 gonorrhea cases, and more than 190,000 syphilis cases were diagnosed, all of which represent a decrease compared to previous years. This decline resulted in a total of over 2.2 million reported STD cases—a notable 9% drop from 2023.
While the overall decline in STDs among adults is encouraging, the rise in congenital syphilis cases is alarming. Congenital syphilis occurs when infected mothers transmit the disease to their newborns, leading to severe health issues such as deafness, blindness, and skeletal deformities. Since 2012, the number of congenital syphilis cases has skyrocketed from about 300 to nearly 4,000 last year, marking a less than 2% increase from 2023. Health experts, including Elizabeth Finley, interim executive director of the National Coalition of STD Directors, express concern over this trend, emphasizing the urgent need to protect both pregnant women and their newborns.
Experts attribute the overall decrease in STDs to a variety of factors. Dr. Jeffrey Klausner, an infectious diseases researcher at the University of Southern California, notes that a general decline in the number of new sexual partners among young people has played a critical role. Furthermore, the increased use of the antibiotic doxycycline as a morning-after treatment for individuals at risk, particularly among gay and bisexual men and transgender women, has also contributed to the decline in adult syphilis cases. According to the CDC, cases of primary and secondary syphilis, which are the most infectious stages of the disease, fell by 22% last year.
The data indicates that improvements in STD rates among adults have not yet translated to better outcomes in obstetric care. A significant challenge remains: only 80% of pregnant women are being screened for syphilis, as highlighted by recent CDC studies. This lack of comprehensive screening is a critical factor in the ongoing rise of congenital syphilis cases, underscoring the need for enhanced prenatal care and awareness.
As health officials continue to monitor these trends, the emphasis on improving screening and preventive measures for pregnant women is crucial in addressing the distressing rise in congenital syphilis cases. The fight against STDs, while showing progress, is far from over, particularly for the most vulnerable populations.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation, but it is solely responsible for all content presented.
